The Technical Analyst
Select Language :
Madrigal Pharmaceuticals [MDGL]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Madrigal Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Madrigal Pharmaceuticals is listed at the  Exchange

4.52% $258.81

America/New_York / 27 mar 2024 @ 16:00


Madrigal Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 5 149.65 mill
EPS: -19.98
P/E: -12.95
Earnings Date: May 06, 2024
SharesOutstanding: 19.90 mill
Avg Daily Volume: 0.565 mill
RATING 2024-03-27
B-
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -12.95 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-2.20x
Company: PE -12.95 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-0.925
(-100.36%) $-259.73
Date: 2024-03-28
Expected Trading Range (DAY)

$ 241.85 - 275.77

( +/- 6.55%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-21 Baker Bros. Advisors Lp Buy 970 951 Common Stock Warrant (right to buy)
2024-03-21 Baker Bros. Advisors Lp Buy 86 741 Common Stock Warrant (right to buy)
2024-03-11 Dier Mardi Sell 0 Common Stock
2024-03-11 Dier Mardi Sell 8 875 Market Stock Unit
2024-03-11 Dier Mardi Sell 13 353 Stock Option (Right to Buy)
INSIDER POWER
-3.59
Last 100 transactions
Buy: 1 310 453 | Sell: 1 604 345

Forecast: 16:00 - $258.75

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $258.75
Forecast 2: 16:00 - $258.75
Forecast 3: 16:00 - $258.75
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $258.81 (4.52% )
Volume 0.399 mill
Avg. Vol. 0.565 mill
% of Avg. Vol 70.65 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Madrigal Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Madrigal Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Madrigal Pharmaceuticals Inc

Last 10 Buy & Sell Signals For MDGL

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$171.59N/AActive
Profile picture for
            Madrigal Pharmaceuticals Inc

MDGL

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Last 10 Buy Signals

Date Signal @
MOWI.OLMar 27 - 08:08NOK198.95
CADLR.OLMar 27 - 08:05NOK53.10
CLUSDMar 28 - 04:46$81.67
NOD.OLMar 27 - 08:05NOK85.80
SOON.OLMar 27 - 08:05NOK67.00
ELO.OLMar 27 - 08:05NOK34.00
VEI.OLMar 27 - 08:05NOK118.00
RIVER.OLMar 27 - 08:0527.00
MAS.OLMar 27 - 08:0530.30
NAVA.OLMar 27 - 07:58NOK35.60

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.